An inexpensive drug produced by a family-owned Canadian firm, which was at the centre of a lengthy court battle, will soon be available to breast and lung cancer patients.
U.S. pharmaceutical giant Bristol-Myers Squibb tried to block the sale of Biolyse Pharma's drug Paclitaxel, arguing the drug was a copy of its own medication.
But the Supreme Court ruled otherwise. Last month, the nation's top court ruled 6-3 in favour of the St. Catharines-based company.
snip
Last month's ruling comes as good news not only for the company, but also for the health-care system.
more
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/1117755005469_16/?hub=Health*** Mods, this was reported late yesterday evening, Thu. Jun. 2 2005 11:26 PM ET, so I hope it still qualifies as breaking news, if not please move as appropriate, thanks)